Lotepro 0.5% is an ophthalmic corticosteroid preparation containing Loteprednol, specifically formulated for the management of steroid-responsive inflammatory conditions of the eye. It is available in ophthalmic gel and suspension forms and is widely used to reduce inflammation, pain, redness, and swelling associated with ocular disorders and post-operative conditions. Lotepro 0.5% is designed to provide effective anti-inflammatory action while minimizing the risk of steroid-related adverse effects when used as directed.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class

Ophthalmic Steroid Preparations

Indications

Lotepro 0.5% is indicated for the treatment of steroid-responsive inflammatory conditions affecting the palpebral and bulbar conjunctiva, cornea, and anterior segment of the eye, including:

• Post-operative inflammation and pain following ocular surgery

• Allergic conjunctivitis

• Acne rosacea involving the eye

• Superficial punctate keratitis

• Herpes zoster keratitis

• Iritis and cyclitis

Both the ophthalmic gel and suspension are effective in controlling inflammation after surgery and in various non-infectious ocular inflammatory conditions.

Pharmacology

Loteprednol is a corticosteroid that exerts its anti-inflammatory effects by inhibiting multiple inflammatory pathways. It induces phospholipase A2 inhibitory proteins, known as lipocortins, which block the release of arachidonic acid from membrane phospholipids. This inhibition reduces the synthesis of inflammatory mediators such as prostaglandins and leukotrienes. As a result, Lotepro 0.5% decreases edema, capillary dilation, leukocyte migration, fibroblast proliferation, collagen deposition, and scar formation associated with ocular inflammation.

Dosage and Administration

The dosage of Lotepro 0.5% depends on the condition being treated and the formulation used.

Steroid-responsive ocular inflammation:

• Instill 1 to 2 drops into the conjunctival sac of the affected eye(s) four times daily.

• During the initial phase, dosing may be increased temporarily if required, under medical supervision.

Post-operative inflammation:

• Instill 1 to 2 drops into the operated eye(s) four times daily, starting 24 hours after surgery and continuing for up to two weeks.

The bottle should be shaken well before use. Care should be taken not to discontinue therapy prematurely. Safety and effectiveness in pediatric patients have not been established.

Drug Interactions

Since Lotepro 0.5% is not detected in plasma following topical ophthalmic administration, clinically significant interactions with systemically administered medicines are not expected.

Contraindications

Lotepro 0.5% is contraindicated in:

• Viral diseases of the cornea and conjunctiva

• Patients with known or suspected hypersensitivity to loteprednol, other corticosteroids, or any component of the formulation

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

Possible side effects include increased intraocular pressure, glaucoma with optic nerve damage, visual field defects, cataract formation, delayed wound healing, secondary ocular infections, and, rarely, perforation of the globe.

Precautions and Warnings

• For ophthalmic use only

• Intraocular pressure should be monitored if used for more than 10 days

• Prolonged use may increase the risk of glaucoma or cataracts

• Use with caution in patients with a history of herpes simplex infection

Pregnancy and Lactation

Lotepro 0.5% is classified as Pregnancy Category C. Its safety during pregnancy and breastfeeding has not been established and should be used only if clearly needed.

Storage

Store in a cool, dry place protected from light. Keep out of reach of children.